SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-16-491827
Filing Date
2016-03-03
Accepted
2016-03-03 17:24:30
Documents
1
Group Members
CL ALASKA, L.P.CRESTLINE INVESTORS, INC. (CRESTLINE)CRESTLINE MANAGEMENT, L.P. (CRESTLINE MANAGEMENT)CRESTLINE SI (GP), L.P. (CRESTLINE SI)

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d154845dsc13da.htm SC 13D/A 91664
  Complete submission text file 0001193125-16-491827.txt   93145
Mailing Address 201 MAIN STREET SUITE 1900 FORT WORTH TX 76102
Business Address
BRATTON DOUGLAS K (Filed by) CIK: 0001281933 (see all company filings)

Type: SC 13D/A

Mailing Address 307 WESTLAKE AVENUE NORTH, SUITE 300 SEATTLE WA 98109
Business Address 307 WESTLAKE AVENUE NORTH, SUITE 300 SEATTLE WA 98109 2066960703
Juno Therapeutics, Inc. (Subject) CIK: 0001594864 (see all company filings)

IRS No.: 463656275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88476 | Film No.: 161482411
SIC: 2836 Biological Products, (No Diagnostic Substances)